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Human skin membranes bind prostaglandin E2 (PGE2) 
vvith high affinity (with an apparent dissociation con-
stant, K.J, of 3.14 x 10-9 M) and specificity. This binding 
is inhibited by trypsin or heat treatment suggesting that 
PGE2 receptors have protein components. 
Exposure of the membranes to ultraviolet irradiation 
(UVB) resulted in the loss of the membrane binding 
capacity for PGE2. This UVB-inhibitory effect could be 
prevented by 5,5'-dithiobis-(2-nitrobenzoic acid), a 
known protein sultbydryl-oxidizing agent and a-tocoph-
erol, a known lipid anti-oxidant. These results suggest 
that UVB-irradiation possibly initiate the reduction of 
critical protein disulfide groups and the peroxidation of 
lipids in the membranes, which are essential for the 
receptor-PGE2 interaction. 
Evidence for the existence of prostaglandin (PG) receptors in 
mammalian tissues and their possible role in the action of 
luteinizing hormone were first reported by Kuehl et al [1,2]. 
Early studies suggested that PG effects are mediated via ligand-
receptor interactions like those of other hormones [3]. More 
recent studies have shown that they are associated with mem-
branes [4-7]. We h ave recently demonstrated that receptors for 
PGE2 and PGF2a are localized in skin membrane fractions, 
particularly those from the smooth endoplasmic reticulum 
(SER) prepared from rat skin [8]. The skin, due to its anatom-
ical location and large surface area, is exposed to a variety of 
environmental factors, most notably ultraviolet (UV)-irradia-
tion from sunlight. A complex relationship has been reported 
to exist between UV -irradiation and PG biosynthesis, metabo-
lism and action in the skin. For instance, UVB-irradiation of 
skin has been associated with increased PGE2 accumulation in 
this tissue with the consequent development of erythema [9-
10]. UV-irradiation in vitro has been associated with increased 
release of arachidonic acid (AA) from membrane phospholipid 
[12] as well as the increased biosynthesis of PGs from AA 
[14]. In our continuing efforts to elucidate the mechanism of 
action of prostaglandins in the skin and what effects UV-irra-
diation might have on this action we have, in this study, 
evaluated: first, whether or not specific receptors for PGE2 exist 
in human skin membrane preparation; secondly, whether or 
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not the exposure of the skin membrane preparation to UV-
irradiation would result in any alteration of the membrane 
binding capacity for PGE2• 
MATERIALS AND METHODS 
[3H]PGE2 (sp. act. 210 /LCi;mmole) and omnifluor (preweighed pack-
ets) were pw-chased from New England Nuclear Corp., Boston, Mass. 
Radiopurity of the prostaglandin was ascertained by thin-layer chro-
matography [8]. Sucrose (enzyme grade), dithiothreitol (DTT), 5,5'-
dithiobis-(2-nitrobenzoic acid) DTNB, EOTA, dextran M.W. 170,000 
bovine serum albumin and the proteolytic enzymes were purchased 
from Sigma Chemical Co., St. Louis, Mo. Solutions of these compounds 
were prepared fresh daily in saline (0.9% w/v). The sodium salt of 
OTNB was prepared by reacting the acid with an equivalent amount 
ofNaHC03 according to Boyne and Ellman [14]. a-Tocopherol (vitamin 
E) was purchased from ICN Biochemicals, Cleveland, Ohio. Unlabeled 
fatty acids (99%) were obtained from Lipid Organic Research, Elysian, 
Minn. Type HA Millipore fIlters (0.45 /Lm pore size) were purchased 
from the Millipore Corp. Bio-Solv and cellulose nitrate test tubes were 
from the Beckman Co., Fullerton, Ca. Sephadex (G-25 coarse) was 
purchased from Pharmacia Fine Chemicals, Inc., Piscataway, N.J. 
The purity of arachidonic acid was ascertained after preparation of 
the methyl ester and analysis by gas- liquid chromatography prior to its 
use. Authentic PGE2, PGF, .. and PGD2 were generously supplied by 
Dr. U.F. Axen of Upjohn Co., Kalamazoo. Reagents were of the highest 
grade commercially available. Organic solvents were redistilled before 
use. Water was distilled and de-ionized. A Westinghouse FS-20 sun 
tube (major emission, 290- 320 nm; intensity 200 /Lw/cm2 at 10 cm) was 
the light source for the UVB-irradiation used in these binding experi-
ments. 
Preparation of Purified J05,OOOg Membrane Fraction 
Epidermal strips were obtained at the time of cosmetic breast surgery 
(mastopexy) from normal human volunteers with informed consent 
previously approved by the University Committee for Protection of 
Human Research. The strips were minced on ice and homogenized with 
3 vol ice-cold 0.25 M sucrose containing 0.05 M Tris-HCI and 0.001 M 
EDTA, pH 7.2. The homogenate was passed through a strainer and the 
solid remainder was rehomogenized with 1 vol buffer. The total ho-
mogenate was poured into polyethylene tubes and subjected to differ-
ential centrifugation as reported previously [8]. 
The 105,000 xg pellet, which contained the crude microsomal· frac-
tion, was resuspended in 6 ml ice-cold 0.01 M Tris-HCI buffer, pH 7.2, 
in a 7 ml Dounce homogenizer (Kontes Glass Co.) according to the 
procedure described by Kornfeld and Siemers [15]. The resuspended 
pellet was carefuUy layered over 6 ml 20% dextran (mol wt 170,000) i,l 
0.01 M Tris-HCI buffer, pH 7.2, and sedimented at 45,000 xg for 1 hr. 
Characterization of the membrane preparation was as reported previ-
ously [8]. Final membrane was resuspended in the same buffer, kept in 
ice and used for binding studies. 
Protein determinations of the membrane fraction was made by the 
method of Lowry et al [16] using the procedure for insoluble proteins. 
In this procedure, the preparations were solubilized by treating with 1 
M N aOH for 30 min at room temperature before the addition of further 
reagents. For routine use, the method was calibrated with bovine serum 
albumin which was used as a standard. 
Preparation of (JH]PGE2 for Binding ,Assay 
The [3H]PGE2 (0.2 /LCi, 0.96-1.12 x 10- .2 mole) in redistilled ethanol 
was pipetted into a disposable glass test tube (12 x 75 mm). The 
ethanol was evaporated under a stream of nitrogen. An appropriate 
amount of 0.01 M Tris-HCI buffer, pH 7.2, was added to the residue. 
The mixture was dispersed in buffer by sonication for 30 sec while 
373 
374 LORD AND ZIBOH 
surrounded in ice and then used for the binding experiments within 60 
min. 
Binding A ssay of !"HjPGE, 
A typical binding reaction was carried out in a total volume of 0.2 ml 
0.01 M Tris-HCI, pH 7.2, containing ["H]PGE2 (0.2 /lCi, 0.96 x 10- '2 
mole), optimal concentration of CaC," (0.5 mM) and resuspended puri-
fi ed membrane fraction (25.0 /lg protein). In each experiment, a parallel 
series of reaction mixtures containing no membrane fractions plus ["H] 
PGE, were run as controls. Incubations were carried out at 4°C as 
reported previously [8]. 
Incubations were stopped immediately by rapidly freezing the incu-
bation tubes in a bucket containing acetone-dry ice. After thawing, the 
contents of the test tube were passed through a Millipore ftIter posi-
tioned on a Millipore manifold under vacuum. Each test tube and ftIter 
was rinsed 3 times with a total of 15 ml Tris-HCI buffer, pH 7.2 The 
amount of radioactivity which was constantly adsorbed to Millipore 
fil ters was determined from the control experiments that contained 
incubated [,JH]PGE, with no membrane fractions. The dried ftIters 
from both experimental groups were then placed in scintillation vials 
containing 2.8% Beckman Bio-Solv and 0.4% Omnifluor (New England 
Nuclear) dissolved in 15 ml toluene and counted in a Packard Scintil-
la tion counter to give the amount of ["H]PGE, bound to protein 
precipitated on the ftIter paper. The amount of contaminating radio-
activity which is adsorbed to ftIter paper was subtracted in every case 
from all incubations of ["H]PGE2 containing membrane preparations. 
Competitive binding studies were carried out by the addition of 
membrane preparations to incubation vials containing radioactive li-
gand-["H]PGE, plus the varying amounts of the respective unlabeled 
PGs and fatty acid. Incubations were carried out in duplicate at each 
concentration and the reaction stopped as described above. The mem-
brane- PGE2 complex was separated from unbound [3H]PGE2 by Milli-
pore fLlter technique described above. "Nonspecific" binding which was 
taken as the binding resistant to large excess of unlabeled PGE2 was 
subtrac ted from the total binding values. This difference is regarded as 
the "specific" binding. In these experiments, nonspecific binding aver-
aged approximately 18% (range 12-25%) of the total binding for ["H] 
PGE2• 
Thin-Layer Chromatography 
To determine whether or not the incubation procedure for the 
binding assay caused an alteration of ["H]PG E2, portions of the ftItrate 
after Millipore ftItration which contained the unbound ["H1PGE2 and 
the bound ["H]PGE2 were extracted 3 times with 5 ml of acidified ethyl 
acetate (2 M citric acid) . Unincubated ["H]PGE2 was treated similarly. 
After drying under a stream of nitrogen, the residues were redissolved 
in minimum amount of chloroform:methanol (1 :1) , applied to silica gel 
",cpa ted ';fLC plates and developed in solvent system diethyl ether: 
methanol:acetic acid (90:1:2) according to Nugteren and Hazelhof 
[17]. The extracts of membrane-bound and free ["H]PGE2 cochromat-
ographed with the unincubated [,'H1PGE, suggesting that no significant 
metabolic conversion of hound and free ["H]PGE2 occurred under our 
incubation conditions. 
UVB -Irradiation of Skin Membranes 
Two series of experiments were carried out to test the effect of UVB-
irradiation on PGE2 binding. In one, the skin membrane was preirra-
diated for 15 min and 30 min respectively under a Westinghouse FS-20 
Sun tube (major emission, 290-320 nm) positioned at a distance of 10 
cm wi th an intensity of 200 /lw/cm2 at this distance. Following irradia-
tion, the me,mbrane was used for the PGE2 binding assay. In another 
series, the [. H1PGE2-bound membrane (PGE2-receptor complex) was 
exposed to UVB-irradiation under the same sun tube for 15 min and 30 
min respectively and the release of ["H]PGE2 was determined. 
RESULTS 
Characteristics of tH}PGE2 Binding to Normal and UVB-
irradiated Human Skin Membrane Fraction 
Specific binding of CH]PGE2 to human skin membranes at 
4°C was saturable at approximately 5.0 X 10- 9 M per 25 /lg 
protein (Fig lA). Assay of the bound and free CH]PGE2 indi-
cated that the radio-ligand was unaltered under the incubation 
conditions. Pre-incubation of the membrane with trypsin 
caused a marked decrease (65%) in its ability to bind [3H]PGE2• 
Furthermore, disruption ofthe membrane phopholipids by pre-
incubation with phospholipase A2 (snake venom from Crotalus 
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adamanteus, 0.5 mg/ mI), retinoic acid (1 x 10- ' M) and cholera 
enterotoxin (freeze-dried vibrio cholerae, 1.0 /lg/mI) also re-
sulted in marked inhibition (94, 98, 100% respectively) of the 
membrane to bind PGE2. 
Heating the membrane preparations to boiling for 10 min 
prior to the binding assay also caused an inhibition (90%) of the 
binding. These results suggest that receptors for ["H]PGE2 have 
protein components which are responsive to digestion by tryp-
sin, responsive to disruption of membrane phospholipids and to 
high temperature. 
Scatchard Analysis 
Scatchard plot [18] of the equilibrium data indicate the 
presence of one population of receptors with an apparent dis-
sociation constant (Kd ) of 3.18 X 10- 9 M and a binding site 
concentration of210 X 10- '1 M (Fig 1B, insert). The high affinity 
binding of PGE2 to the human skin membrane preparation 
compares well with similar binding of PGEz to rat skin smooth 
endoplasmic reticulum preparation [8] and in other tissues 
[19,20]. 
The specificity of the CH]PGE2 binding was established by 
incubating simultaneously varying amounts of unlabeled pros-
taglandins and arachidonic acid with CH]PGE2 and the mem-
brane preparation_ The data in Fig 2 demonstrated that unla-
beled PGE2 competed most effectively (82%) with CH]PGE2 for 
the binding sites whereas unlabeled PGD2 and PGF2n competed 
less effectively (70% and 25%) respectively_ Arachidonic acid (a 
precursor for PGs) did not compete with CH]PGE2 for the 
receptor sites. A Lineweaver-Burk plot [21] of the inhibition 
data revealed a simple competitive inhibition of the [,JH]PGE2 
specific binding by the prostaglandins (Fig 3). 
Effect of UVB-irradiation on the Affinity of Skin Membranes 
for PGE2 
A report [22] that UV -irradiation (254 nm) may impair the 
ability of the platelet membrane-bound PGE, to inhibit platelet 
aggregation by initiating the reduction of critical disulfide 
groups in the vic inity of the PGEI-membrane receptor complex 
stimulated us to test whether or not the exposure of skin 
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FIG 1. Binding of [' H]PGE, to human skin membrane. 0.2 mI sus-
pensions of membrane preparations (25 /lg protein) in 0.01 M Tris-HCI 
buffer, pH 7.2, containing CaCl, (0.5 mM) were incubated with increas-
ing concentrations of ["H]PGE, at 4 °C for 30 min. Separation of bound 
and free ["H1PGE2 was by Millipore ftlter as described in Materials and 
Methods. Each value, after correction for nonspecific binding, repre-
sents the mean of duplicate determinations from 3 experiments and the 
values agreed within 10% of the means. The fig represents the binding 
of [' H]PGE2 to the skin membrane preparation and insert represents 
the Scatchard plot of the binding data. The intercept on the abscissa 
represents the concentration of binding sites (210 x 10- '2 M). 
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FIG 2. Specificity of [ "H]PGE~ binding to skin membrane. 0.2 ml 
s u spensions of membrane preparations (25 Jlg protein) in 0.01 M Tris-
He! buffer, pH 7.2, conta ining CaCb (0.5 mM) were incubated with ["H) 
PGE~ (0.02 Jlei; 0.96 x 10- 12 mol) in the presence of arachidonic acid 
and 3 prostaglandins: arachidonic ac id, 0-0; prostaglandin F2." .-
&; prostaglandin D" *- *; and prostaglandin E~, e-e. Specific bind-
ing from incuba tions without unlabeled substances was taken as 100%. 
The values represent the means of duplicate determinations from 3 
experiments and the values agreed within 10% of the means. 
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FIG 3. Lineweaver-Burk plot of the inhibition data in Fig 2. The 
data represent mean values of duplicate determinations from 3 separate 
experiments. 
membranes to UVB-irradiation would also alter their ability to 
bind PGE2 • 
Results from the 2 series of experiments are shown in Fig 4 
(A and B). In the first instance, exposure of the skin membrane 
preparation to UVB-irradiation for 15 and 30 min prior to the 
binding assay resulted in 60 and 80% decrease in [:JH]PGE2 
binding respectively (A) . In the second instance, exposure of 
t he bound PGE2 (PGEz-receptor complex) to UVB-irradiation 
for 15 and 30 min resulted in rapid release of free [3H]PGE2 
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from the membrane PGE2-receptor complex approximately 40 
and 80% respectively (B) . In control experiments where the 
PGE2-receptor complex was incubated without UVB-irradia-
tion for up to 30 min the PGE2-bound membrane was relatively 
stable and release of ["H]PGE2 was less than 15%. Scatchard 
plot after the irradiation of the membrane preparation revealed 
a marked increase in the apparent Kd (2.2 x 10- 8 M) with 
decreased affinity (Fig 5) . 
Effect of Protein Modifying Reagents on UVB-induced 
Inhibition of fH}PGE 2 Binding to Skin Membranes 
To test the hypothesis proposed by Johnson, Jessup, and 
Ramwell [22] that UV -irradiation may initiate the reduction of 
disulfide bonds near the PGEI-receptor, DTT, a known reduc-
ing agent, and DTNB, a known substance for the oxidation of 
sulfhydryl groups were added at a concentration of 1 x 10- 4 M 
respectively to the membrane preparations during exposure to 
UVB-irradiation and prior to the binding assay. Results of these 
experiments are shown in Fig 6. Exposure of the membranes 
alone or the membranes plus DTT to UVB-irradiation resulted 
in inhibition of binding of the membranes to [3H]PGE2 (70% 
and 62% respectively). On the other hand, exposure of the 
membranes plus DTNB to UVB-irradiation prior to the binding 
assay prevented the UVB-induced inhibition of [3H]PGE2 bind-
ing to the membranes. In another experiment, exposure of the 
membranes to UVB-irradiation in the presence of both DTT 
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FIG 4. Effect of UVB-irradiation on the binding of ["H]PGE2 to skin 
membrane. 0.2 ml suspensions of skin membrane preparations (25 Jlg 
protein) were exposed to a Westinghouse FS-20 sun tube positioned at 
a distance of 10 cm (major emission, 290-320 nm, with intensity of 200 
Jlw/cm2 ) for 15 min and 30 min respectively. Following irradiation, 
suspensions were incubated wi th ["H]pGE2• Details of experimental 
procedures are as described under Fig 1. Each value represents the 
mean ± SEM of duplicate experiments and the values agreed within 
10% of the means. 
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FIG 5, Comparison of Scatchard plot analysis of ["H]PGE2 binding 
to UVB-irradiated and nonirradiated skin membrane, Experiments of 
["H]PGE2 binding to UVB-irradiation and non irradiated skin mem-
brane preparations are as described under Fig 1. Each value represents 
the mean of duplicate determinations from 3 experiments, The inter-
cepts on the abscissa represent the concentration of binding sites. 
and DTNB prior to the binding assay produced an intermediate 
effect (data not shown). Furthermore, separate incubations of 
the membranes with DTT or DTNB in the absence of UVB-
irradiation resulted in no change in binding of the membranes 
to [3H]PGE2 , 
Effect of an Antioxidant on UVB-induced Inhibition of 
fH]PGE 2 Binding to'Skin Membranes 
Ultraviolet irradiation has been reported to trigger a variety 
of phenomena in cells among which are the initiation of lipid 
peroxidation [23] and the formation of free radicals [24]. Since 
a-tocopherol (vitamin E) has received a wide support for many 
years as an antioxidant and as an antifree radical substance 
[25,26], we tested whether or not this substance will protect the 
membrane preparations from the UVB-induced inhibition of 
binding to PGE2. Thus, a-tocopherol (1 X 10- 2 M) was added to 
the membranes prior to exposure to UVB-irradiation, Results 
in Fig 7 demonstrate that a-tocopherol prevented the UVB-
induced inhibition of PGE2-binding. 
DISCUSSION 
The present study has demonstrated that binding of eH] 
PGE2 to human skin membranes is similar to that reported for 
rat skin [8]. Since PGE2 is known to exert a variety of effects in 
the skin, notably, the activation of the adenylcyciase system 
[27,28], it is likely that a relationship exists between the binding 
of PGE2 to skin membrane and its activation of adenylcyciase 
system in this tissue. Although this relationship was not estab-
lished in our system, it has nonetheless been demonstrated in 
membrane preparations and cells from other systems [29-32]. 
The capacity of ultraviolet irradiation to trigger a variety of 
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phenomena in cells such as the peroxidation of membrane lipids 
[34], the formation of free radicals [24], the reduction of disul-
fide bonds [22], the damage to DNA and other macromolecules 
[33] as well as the activation of prostaglandin biosynthesis and 
the activity of phospholipase A [12] have been amply described, 
It is reasonable therefore, to expect that undue exposure of the 
skin to ultraviolet irradiation could result in alteration of the 
tissue membrane which in turn may affect the affinity of the 
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FIG 6. The effect of protein modifying reagents on UVB-induced 
inhibit ion of ["H]PGE2 binding of skin membrane. 0.2 ml suspensions 
of membrane preparations (25 !lg protein) containing DTT or DTNB 
(1 X 10- " M) were exposed to Westinghouse FS-20 sun tube as described 
under Fig 4. Control suspensions were either exposed or not exposed to 
UVB-irradiation. Following irradiation, the suspensions were incubated 
with ["H]PGE2. The vertical bars represent the means of duplicate 
determinations ± SEM from 3 separate experiments. 
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FIG 7. The effect of an antioxidant on UVB-induced inhibition of 
[3H]PGE2 binding to skin membrane. 0.2 ml suspensions of membrane 
preparations (0.25!lg protein) containing a-tocopherol (1 x 1O-~) were 
exposed to Westinghouse FS-20 sun tube as described under Fig 4. 
Control suspensions were either exposed or not exposed to UVB-
irradiation. Following irradiation, the suspensions were incubated with 
[3H]PGE2• The vertical bars represent the means of duplicate deter-
minations ± SEM from 3 experiments. 
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m e mbrane for PGE2 . Thus, our in vitro data as shown in Fig 5 
d e monstrated: (i ) that prior exposure ofthe membrane to UVB-
irradiation inhibited the capacity of the membrane to bind CH] 
P GE2 and (ii) that exposure of the bound CH]PGE2-me; .:' -Im e 
complex to UVB-irradiation resulted in rapid release of fr ee 
e H]PGE2 from the CH]PGE2-membrane complex. This latter 
o b servation is particularly interesting in view of the suggestion 
[34] that UVB-induced erythema is biphasic: a first phase 
transient erythema occurring within the first 15 min following 
exposure to UVB-irradiation, which disappears soon after-
wards, and a second phase erythema which appears in approx-
ima tely 2 hr and then lasts for 48 hr. The second phase has 
been associa ted with the biosynthesis of new PGE2 since this 
e rythema can be blocked by indomethacin (a cyclooxygenase 
inhibitor) . The nature of the early transient erythema has 
remained unclear, although its emergence has been attributed 
to t he release of histamine because it cannot be blocked by 
indomethacin [9,34,35]' If our in vitro observations are consist-
e n t wit h in vivo situations, it is conceivable that after exposure 
of t h e skin to UVB-irradiation the PGE2 bound to the epidermal 
membrane receptors can be released immediately (Fig 4) , caus-
ing the dilatation of the skin blood vessels and the visible 
transient erythema. This will be consistent with the inability of 
indomethacin to block the action of already formed PGE2• It is 
also interesting that Mathur and Gandhi [10] in one of the 
earlier studies on UV -irradia tion and skin postulated that UVB-
induced erythema could be due at least in part to the release of 
preformed prostaglandins. Further studies are however neces-
sary to elucidate these phenomena. 
T he suggestions that ultraviolet irradiation could induce the 
reduction of disulfide bonds [22] and that disulfide-sulfhydryl 
m ay play important roles at or near the PGE,-receptor site [36] 
wer e examined in our studies. Our data as shown in Fig 6 
s uggests that the protection of disulfide groups at or near the 
m e mbra ne receptor site can prevent the destructive effects of 
the UVB-irradiation. Whether or not UVB-irradiation actually 
caused the reduction of disulfide bonds in our skin membrane 
pre parations was not determined in our preparations. Our in-
direct studies do suggest however, that modifiers of protein 
s ulfhydryl groups do alter the binding characteristics of our 
membrane preparations. 
Another line of observation in our studies is the possible role 
of m embrane lipids in the receptor-ligand interaction. For in-
stance, our observation with regard to the effect of a -tocopherol 
(vi t amin E) on UVB-induced inhibition of ["H]PGE2 binding to 
th e skin membrane preparation is shown in Fig 7. Since a-
tocopherol (a known antioxidant with a suggested possible 
structural role in membranes) prevents the UVB-induced in-
hibition of CH]PGE2 binding to skin membrane preparation, it 
is reasonable to suggest that the maintenance of normal integ-
rity of membrane lipids may be an essential factor for the 
binding of skin membrane receptors to eH]PGE2• 
T hus another essentiality to be considered in the phenome-
non of prostaglandin-membrane receptor interaction must in-
volve not only t he protein component of the receptor but also 
the membrane lipid component associated with the receptor. 
T he author thanks Miss Edna Wehby for typing the manuscript and 
for t he preparation of the figures. 
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